Bridging Biology and Informatics for R&D Innovation
Eagle Genomics’ 5th annual symposium will focus on the challenges faced by the research community in bridging biology and informatics to uncover significant global discoveries in human health. Our programme is presented by thought leaders, scientists and key pioneers working on important advancements in their respective fields. The symposium attempts to find communality in addressing microbiology, disease research, and drug development. The day will be spent exploring how computational biology is being applied in R&D in such areas as antimicrobial resistance, personalised medicine, and therapeutic target validation.
During the symposium, the speakers will share with the delegates innovative approaches used in research, the challenges, and resulting solutions to showcase how they have opened up new frontiers in life sciences.
This year we focus on the following four sessions:
- Microorganisms, disease resistance and genome editing
- Clinical genomics and personalised medicine
- Molecular information in therapeutic drug development
- Keynote Address, Dr. Ewan Birney FRS, Joint Associate Director, EMBL-EBI
- Ewan Birney FRS, EMBL-EBI – Keynote Speaker, Joint Associate Director EMBL-EBI – Read about Ewan’s talk
- Simon Andrews, Babraham Institute – Head of Bioinformatics – Read about Simon’s talk
- Claus Bendtsen, AstraZeneca – Head of Computational Biology – Read about Claus’ talk
- Mario Caccamo, TGAC – Director
- Richard Dobson, The NIHR Biomedical Research Centre for Mental Health, Kings College London – Head of Bioinformatics – Read about Richard’s talk
- Barry Murphy, Unilever – Microbiomics Science Lead – Read about Barry’s talk
- Vincent Plagnol, Inivata, UCL – Head of Computational Biology and Reader – Read about Vincent’s talk
- Sobia Raza, PHG Foundation – Interim Programme Lead – Science – Read about Sobia’s talk
- Joke Reumers, Janssen– Senior Scientist – Read about Joke’s talk
- Philippe Sanseau, GSK – Head Computational Biology – Read about Philippe’s talk
- William Spooner, Eagle Genomics – CSO
- David Williams, Discuva – CEO – Read about David’s talk
Eagle Genomics is proud to have as our Keynote speaker: Dr Ewan Birney, FRS, Joint Associate Director, EMBL-EBI. Dr Birney is one of the founders of the Ensembl genome browser and has joint strategic responsibility and oversight for bioinformatics services at EMBL-EBI. He played a vital role in annotating the genome sequences of the human, mouse, chicken and several other organisms; this work has had a profound impact on our understanding of genomic biology. He led the analysis group for the ENCODE project, which is defining functional elements in the human genome. His main areas of research include functional genomics, assembly algorithms, statistical methods to analyse genomic information (in particular information associated with individual differences) and compression of sequence information. He completed his PhD at the Wellcome Trust Sanger Institute with Richard Durbin, and worked in the laboratories of leading scientists Adrian Krainer, Toby Gibson and Iain Campbell. Ewan has received a number of prestigious awards including the 2003 Francis Crick Award from the Royal Society, the 2005 Overton Prize from the International Society for Computational Biology and the 2005 Benjamin Franklin Award for contributions in Open Source Bioinformatics. Ewan Birney was elected Fellow of the Royal Society in 2014.
Who should attend?
- Scientists using computational approaches to address biological questions
- Informaticians developing tools that can be applied to biology
- Data managers working with biological information
- R&D professionals at all levels with an interest in the field
Since its début in 2011, the annual eaglesymposium has become Cambridge’s premiere one-day event to discuss the latest trends and practices in computational biology and bioinformatics. Each year we hear from the scientists themselves, both commercial and academic, who are transforming these fields. Our previous delegates have repeatedly stated how they have highly valued the symposium for informative sessions with impactful applications that clearly outline new advances in research.
8.30am – Arrival and Breakfast
9.10am – Welcome
9.20am – Session 1: Microorganisms, disease resistance and genome editing
11:00am – Coffee Break
11.30am – Session 2: Clinical genomics and personalised medicine
1.10pm – Lunch
2.10pm – Session 3: Molecular information in therapeutic drug development
3.50pm – Coffee Break
4.20pm – Keynote Address, Dr. Ewan Birney FRS
5.10pm – Drinks Reception
In 2015 we will be hosting our symposium at the Kendrew Lecture Theatre at the European Bioinformatics Institute (EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. A state of the art conference facility, located in Hinxton 5 miles away from Eagle’s HQ at Babraham. Hotels will be available to book at the Hinxton campus. Please contact us for more details.
We recommend booking the on-site Wellcome Trust Conference Centre accommodation, which
provides a high level of comfort (3*) with free wireless internet, set in lovely parkland surroundings. Email the centre to book a room.
The Red Lion which is 2 minutes walk from campus and has 8 rooms available. Contact via phone: +44 (0)1799 530601
This Year's Sessions
Early bird discount rate is £99+VAT (up to 16 Feb 2015).
Standard rate is £195+VAT (after 16 Feb 2015).
20% group discount with registration of 3 or more people.
All registrations include conference access, breakfast, lunch, coffee breaks and a drinks reception at the end.
Previous attendees quotes
“Nice mix of Pharma, academia and SME!”K. B. , CEO
“Excellent range of high quality talks!”S. C. , KEC Manager
“Really good diversity in the talks. Different perspectives, well highlighted by Abel in the beginning. Good welcoming notes. A lot of questions from the audience to the speakers. Great panel chairman.”I.K. , Event organiser
“Excellent set of diverse and interesting talks.”J.R. , Head of Life Science
“I enjoyed all the talks and found them generally easy to follow and interesting.”K. B. , Senior Consultant
“Nice mix of technical and popular material.”W. N. , Senior Consultant